Zilver Flex 35 Vascular Stent
Cook Ireland, Ltd. · Decision date Oct 22, 2025
What did the FDA approve?
FDA records P050017/S025 as a supplement to PMA P050017, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Oct 22, 2025.
FDA approval order statement
requested updates to your device labeling, including the graphics, operating principles, precautions and procedural instructions
- Regulatory pathway
- PMA supplement
- Supplement type
- Special (Immediate Track)
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 22, 2025
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P050017/S025
- Regulatory pathway
- PMA supplement
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIO
- Decision code
- APPR
- Decision date
- Oct 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P050017. Subsequent supplements may change the device or its indications.
FDA decision timeline
P050017 · Original PMA
ZILVER VASCULAR STENT
P050017/S025 received
Application receipt date recorded by FDA.
P050017/S025 · FDA decision
Special (Immediate Track)
P050017/S026 · Related supplement
Zilver Flex 35 Vascular Stent; Zilver 635 Vascular Stent; Zilver 518 Vascular Stent
P050017/S027 · Related supplement
Zilver 635 Vascular Stent, Zilver 518 Vascular Stent
Timeline entries are records held by MedtechLedger for P050017. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P050017
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ZILVER VASCULAR STENTP050017 | Cook Ireland, Ltd. | PMA approval | Jun 26, 2006 | FDA |
| Cook Ireland, Ltd. | PMA supplement | Apr 14, 2026 | FDA | |
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
Epic Vascular Self-Expanding Stent SystemP110035/S079 | Boston Scientific Corp | PMA supplement | Aug 21, 2026 | FDA |
Epic Vascular Self-Expanding Stent SystemP110035/S078 | Boston Scientific Corp | PMA supplement | Aug 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Ireland, Ltd.
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- O' Halloran Rd., National Technology Park, Limerick
Sources and methodology
- Original FDA record: P050017/S025
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





